Kusne S, Dummer J S, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis A G, Starzl T E, Ho M
Department of Medicine, School of Medicine, University of Pittsburgh, PA 15261.
Medicine (Baltimore). 1988 Mar;67(2):132-43. doi: 10.1097/00005792-198803000-00006.
We studied infections in 101 consecutive patients who underwent liver transplantation between July 1984 and September 1985. The mean length of follow-up was 394 days. Eighty-three percent of population had 1 or more episodes of infection and 67% of the population had severe infections. The overall mortality was 26/101 (26%) and 23 of 26 deaths (88%) were associated with infection. Seventy percent of severe infections occurred in the first 2 months after transplantation. The most frequent severe infections were abdominal abscess, bacterial pneumonia, invasive candidiasis, Pneumocystis pneumonia, and symptomatic cytomegalovirus infection. Patients with more than 12 hours of cumulative surgical time had a higher rate of severe infections (P less than 0.001), particularly fungal (P less than 0.001) and bacterial (P less than 0.01) infections. Also, the use of choledocho-jejunostomy was associated with a higher rate of infection in patients who had more than 1 transplant operation (P less than 0.02). No increase in infection was found in patients who received azathioprine, or more than the median number of steroid boluses or "recycles"; but patients who received OKT3 therapy had a higher rate of protozoal infections (P less than 0.05). A result similar to that of our previous studies was a strong relation between the number of severe fungal infections and prolonged courses of antibiotics after transplant operation (P less than 0.001). Pretransplant manifestations of severe liver disease such as ascites, encephalopathy, and gastrointestinal bleeding were not associated with higher rates of infection after transplantation, but high serum levels of ALT were. Patients with lower ratios of T-helper to T-suppressor lymphocytes had more severe viral (P less than 0.02) and fungal (P less than 0.01) infections after transplantation.
我们研究了1984年7月至1985年9月期间连续接受肝移植的101例患者的感染情况。平均随访时间为394天。83%的患者发生过1次或更多次感染,67%的患者发生过严重感染。总死亡率为26/101(26%),26例死亡中有23例(88%)与感染有关。70%的严重感染发生在移植后的前2个月。最常见的严重感染是腹腔脓肿、细菌性肺炎、侵袭性念珠菌病、肺孢子菌肺炎和有症状的巨细胞病毒感染。累计手术时间超过12小时的患者严重感染率更高(P<0.001),尤其是真菌(P<0.001)和细菌(P<0.01)感染。此外,在接受过1次以上移植手术的患者中,使用胆肠吻合术与感染率较高有关(P<0.02)。接受硫唑嘌呤、超过类固醇冲击剂量中位数或“再循环”次数的患者感染率没有增加;但接受OKT3治疗的患者原生动物感染率较高(P<0.05)。与我们之前的研究结果相似的是,移植后严重真菌感染的数量与抗生素使用疗程延长之间存在密切关系(P<0.001)。移植前严重肝病的表现,如腹水、肝性脑病和胃肠道出血,与移植后较高的感染率无关,但血清ALT水平高则有关。移植后T辅助淋巴细胞与T抑制淋巴细胞比例较低的患者有更严重的病毒(P<0.02)和真菌(P<0.01)感染。